【LB Pharmaceuticals(LBRX.US)冲刺纳斯达克 拟募资1亿美元 有望打破生物科技IPO寒冬】智通财经APP获悉,聚焦于神经精神疾病药物的生物科技公司 LB
Pharmaceuticals于上周五提交了规模约1亿美元的美国股市首次公开募股(IPO)申请,标志着自今年1月以来首个来自创新药物开发商或者生物科技公司的重要新IPO申请。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.